Head-to-Head

ABBVIE INC. vs. Arcutis Biotherapeutics, Inc. Common Stock

ABBV

ABBVIE INC.

$263.96 -0.02%

VS ARQT

Arcutis Biotherapeutics, Inc. Common Stock

$24.25 +1.53%

ABBVIE INC. (ABBV) comes out ahead, leading on 6 of 9 compared factors.

Size & Scale

ABBVARQT
Market Cap $466.45 billion $3.00 billion
Revenue (TTM) $64.39 billion $463.98 million
Net Income (TTM) $6.32 billion $28.52 million

ABBV leads on 3 of 3 size & scale factors.

Valuation

ABBVARQT
P/E Ratio 74.56 115.48
Price / Book -79.22 13.61
Price / Sales 7.24 6.47

ABBV leads on 2 of 3 valuation factors.

Profitability

ABBVARQT
Net Margin 9.81% 6.15%
Return on Equity -107.29% 12.93%

ABBV and ARQT split the profitability factors evenly.

Dividend

ABBVARQT
Dividend Yield 2.62% —
Payout Ratio 195.48 —

ABBV and ARQT split the dividend factors evenly.

Risk & Sentiment

ABBVARQT
Short Interest 0.85% 0.19%

ARQT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, ARQT overview, ARQT financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.